Gene symbol | CCNG1 | Synonyms | CCNG | Type of gene | protein-coding |
Chromosome | 5 | Map location | 5q34 | dbXrefs | |
Description | cyclin G1 |
GTO ID | GTC1230 |
Trial ID | NCT00121745 |
Disease | Pancreatic Cancer |
Altered gene | CCNG1 |
Therapeutic/Target gene | Therapeutic gene |
Therapy | Gene transfer |
Treatment | Rexin-G |
Phase | Phase1 |
Recruitment status | Terminated |
Title | Phase I Evaluation of Safety of Intravenous Infusion of a Pathotropic Vector Bearing a Cytocidal Cyclin G1 Construct (Rexin-G) as Intervention for Locally Advanced and Metastatic Pancreatic Cancer Refractory to Standard Chemotherapy |
Year | 2005 |
Country | United States |
Company sponsor | Epeius Biotechnologies |
Other ID(s) | MC044C |
Vector information | |||
|
Cohort1: dose level 1 | |||||||
|
|||||||
Cohort2: dose level 2 | |||||||
|
|||||||
Cohort3: dose level 3 | |||||||
|
|||||||
Cohort4: dose level 4 | |||||||
|